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Objective: Different vascular beds show differing susceptibility to the development of 
atherosclerosis, but the molecular mechanisms underlying these differences are incompletely 
understood. This study aims to identify factors that contribute to the phenotypic heterogeneity of 
distinct regions of the adult vasculature. 
 
Approach/Results: High-throughput mRNA profiling in adult mice reveals higher expression of the 
homeobox paralogous genes 6 to 10 (Hox6-10) in the athero-resistant thoracic aorta (TA) versus the 
athero-susceptible aortic arch (AA). Higher Hox gene expression also occurs in rat and porcine TA, 
and is maintained in primary smooth muscle cells isolated from TA (TA-SMCs) compared with cells 
from AA (AA-SMCs). This region-specific homeobox gene expression pattern is also observed in 
human embryonic stem cells differentiated into neuroectoderm-SMCs and paraxial mesoderm-
SMCs, which give rise to AA-SMCs and TA-SMCs, respectively. We also find that, compared with 
AA and AA-SMCs, TA and TA-SMCs have lower activity of the pro-inflammatory and pro-
atherogenic transcription factor NF-κB and lower expression of NF-κB target genes, at least in part 
due to HOXA9-dependent inhibition. Conversely, NF-κB inhibits HOXA9 promoter activity and 
mRNA expression in SMCs. 
 
Conclusions: Our findings support a model of Hox6-10-specified positional identity in the adult 
vasculature that is established by embryonic cues independently of environmental factors and is 
conserved in different mammalian species. Differential Hox expression contributes to maintaining 
phenotypic differences between SMCs from athero-resistant and athero-susceptible regions, at least 
in part through feedback regulatory mechanisms involving inflammatory mediators, for example 








Animal and human studies have conclusively established that different blood vessels and distinct 
segments within a given artery are heterogeneous in their susceptibility to developing vascular 
pathologies in response to common risk factors.1-3 Differences in flow patterns and hemodynamic 
forces within the vascular system are thought to play a major role in establishing regional 
heterogeneity in the susceptibility to vascular disease initiation and progression.4-6 For example, 
vascular regions with low shear stress or oscillatory and turbulent shear stress, such as regions of 
curvature and branching, are more susceptible to atherosclerotic plaque formation. In contrast, 
straight vessel segments with laminar blood flow are relatively resistant to atherosclerosis 
development. Moreover, there is evidence that, independently of hemodynamic factors, intrinsic 
cellular features that in part reflect distinct embryonic origins also contribute to establishing 
heterogeneous vascular responses to particular biological or pathological stimuli in adult 
organisms.7, 8 For example, using a canine model of homograft transplantation, Haimovici and Maier 
found that atherosclerosis-prone abdominal aortic segments transplanted into atherosclerosis-
resistant regions develop atherosclerosis, and that conversely, atherosclerosis-resistant vessels fail 
to develop intimal lesions when transplanted into atherosclerosis-prone positions in the abdominal 
aorta.9, 10 It is also noteworthy that some regional heterogeneity of the vascular system is maintained 
in vitro.7, 8 For example, cell proliferation and migration, both of which contribute to atherosclerosis 
development,11, 12 are greater in primary smooth muscle cells (SMCs) derived from atherosclerosis-
prone coronary artery and aortic arch than in SMCs from athero-resistant femoral arteries.13, 14 
Previous studies demonstrated variation in susceptibility to atherosclerosis among inbred 
strains of wild-type mice fed an atherogenic diet, with C57BL/6J being the most susceptible.15 
Disease progression is aggravated in mice deficient for apolipoprotein E (apoE-KO), which show 
impaired clearing of plasma lipoproteins and develop atherosclerosis in a short time.16 In the present 
study, we performed high-throughput transcriptomic studies in aorta of young C57BL/6J wild-type 
and apoE-KO mice fed low-fat standard chow to identify novel mediators that contribute to 
establishing phenotypic differences between the highly atherogenic aortic arch (AA) and the athero-
resistant thoracic aorta (TA) at pre-lesional stages. We focused on genes displaying differential 
expression in AA compared with TA in both wild-type and apoE-KO mice, since these genes are 
more likely to be regulated by positional cues independently of genotype. We demonstrate that 
transcription factors of the homeobox gene family show significant differences in mRNA and protein 
expression between adult TA and AA in wild-type and apoE-KO mice. Homeobox genes encode 
homeodomain-containing transcription factors that are master regulators of embryonic development 
and specify cell fates along the anterior-posterior axis of all bilaterian embryos from a wide range of 
evolutionarily very distant animal species.17-20 The class I vertebrate homeobox genes (HOX in 
humans and pigs, Hox in mice and rats) include 39 members organized in four paralogous clusters 
(Hoxa, Hoxb, Hoxc, Hoxd) that are located in different chromosomes (see Fig.2B). During 
development, Hox genes are expressed in a temporally and spatially colinear pattern, with the most 
3’ members of each cluster being expressed earlier in embryonic development and predominantly in 
anterior regions, while the most 5’ genes are activated later, mainly in posterior tissues.17-20 We 
report that differences Hox gene expression between TA and AA found in the mouse are conserved 
in rats and pigs, and are maintained in primary adult SMCs and in developmental-origin-specific 
human SMCs cultured under static conditions. We also provide evidence that differences in Hoxa9 
expression in distinct vessel segments contribute to establishing differential activity of the pro-






Global analysis of gene expression in mouse aortic arch and thoracic aorta. To identify factors 
involved in establishing vascular heterogeneity that may contribute to atherosclerosis development 
in adulthood, we performed high-throughput transcriptomic analysis of athero-susceptible AA and 
athero-resistant TA isolated from young wild-type and apoE-KO mice fed control chow. As expected, 
wild-type mice were normocholesterolemic and apoE-KO mice exhibited mild hypercholesterolemia 
(Fig.1A). Consistent with a very early stage of atherosclerosis development, atherosclerotic lesions 
in the aortic sinus of apoE-KO mice were absent or very incipient, as demonstrated by 
immunohistochemical analysis with macrophage-specific anti-Mac-3 antibody (Fig.1B), and 
atherosclerotic lesions were completely absent from wild-type mice (data not shown). We hybridized 
labeled aRNA from pooled AA and TA to Agilent Whole Mouse Genome Microarrays (Fig.1C). After 
normalization and filtering of data as described in Materials and Methods, we focused on 
differentially expressed genes (adjp ≤ 0.05) showing differences in expression of at least two-fold 
between TA and AA for at least one genotype. Using these criteria, we identified a total of 368 
genes differentially expressed in TA compared with AA (Fig.1C), of which 122 were differentially 
expressed only in apoE-KO mice (36 upregulated, 86 downregulated, Supplemental Table II), 27 
only in wild-type mice (17 upregulated, 10 downregulated, Supplemental Table III), and 219 in both 
genotypes (82 upregulated, 137 downregulated, Supplemental Table IV) (Fig.1C).  Supplemental 
Table V shows the functional classification of all the genes differentially expressed between TA and 
AA according to the Biological Process gene ontology terms (level 1) using the online software The 
Database for Annotation, Visualization and Integrated Discovery (DAVID, v6.7).  
 
Differential regulation of class I homeobox genes in mouse aorta. We focused on genes that 
were differentially expressed between TA and AA in both wild-type and apoE-KO mice, since these 
are more likely to be regulated by positional cues independently of genotype. We noted that a 
subset of 11 TA-enriched genes in the Developmental Processes category were homeobox genes 
(Supplemental Table V). Indeed, the most upregulated gene in our microarray analysis is Hoxc9, 
and 6 out of the 10 most upregulated transcripts in TA also correspond to Hox genes 
(Supplemental Table IV). The magnitude of the increase in Hox expression is similar for both 
genotypes (Fig.2A), consistent with the notion that they are truly regulated in a region-dependent 
manner and independently of the genotype. Our microarray studies also reveal that Hoxb8 and 
Hoxc8 are expressed at higher level in TA versus AA in apoE-KO mice, but not in wild-type mice 
(Fig.2A).  
Consistent with the spatial colinearity that characterizes the Hox cluster genes during 
embryonic development,17-20 all the Hox genes that are expressed at higher level in mouse TA 
versus AA, with the sole exception of Hoxd4, belong to paralogous groups 6 to 10 of the four Hox 
clusters (Fig.2B). qPCR analysis of fresh RNA preparations (4 pools each containing 3 AAs or 3 
TAs) confirmed higher expression of Hox6-10 transcripts in TA from wild-type mice (Fig.3A, left), 
including some members of these paralogous groups which were either not detected in wild-type 
tissue or did not pass the selection criteria in the microarray analysis. Western blot analysis of 3 
independent pools of aortic tissue confirmed higher expression of Hoxa9 and Hoxc8 proteins in 
mouse TA compared with AA (Fig.3B). In contrast, expression of the 3’-most genes Hoxa1 and 
Hoxa2 did not differ between AA and TA (Supplemental Fig.I). These results show that spatial 
colinearity is also a characteristic of Hox gene expression in the adult mouse aorta. 
To ascertain whether differential Hox expression is maintained in culture, we performed 
qPCR in primary SMCs isolated from mouse AA (AA-SMCs) and TA (TA-SMCs). These studies 
revealed higher Hox6-10 expression in TA-SMCs versus AA-SMCs, although Hoxd8 differential 
expression was not statistically significant (Fig.3A, right).  
  
Regional differences in Hox expression in aorta are conserved in rats and pigs. In order to 
determine if the Hox expression pattern in the adult vasculature is conserved in mammals, we 
performed mRNA expression studies in aorta from rats and pigs. As in the mouse models, Hoxc8, 
Hoxa9 and Hoxc9 are expressed at higher level in rat TA and TA-SMCs than in AA and AA-SMCs 
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(Supplemental Fig.II). In contrast, expression of the 3’-most genes Hoxa1 and Hoxa2 is lower in rat 
TA and TA-SMCs (Supplemental Fig.I). Higher levels of HOXC8, HOXA9 and HOXC10 expression 
in TA compared with AA was also detected in pig (Supplemental Fig.II).  
 
Human neuroectoderm-derived and paraxial mesoderm-derived smooth muscle cells exhibit 
differential homeobox gene expression. The vasculature is formed by SMCs from different 
embryological origins.7, 8 Lineage mapping studies have shown that neural crest cells give rise to 
AA-SMCs whereas TA-SMCs derive from paraxial mesoderm.7, 21 We therefore examined HOX 
expression in human neuroectoderm-derived SMCs (NE-SMCs) and paraxial mesoderm-derived 
SMCs (PM-SMCs) differentiated from pluripotent human embryonic stem cells (Fig.4A).22 These in-
vitro-derived cells express markers of differentiated SMCs and recapitulate the unique proliferative 
and secretory responses to cytokines characteristic of their in vivo aortic SMC counterparts of 
distinct embryonic origin.22 In agreement with our analysis in animal models, microarray studies 
showed higher expression of HOXB6, C6, B7, B8, C8, A9, C9, A10 and D10 genes in human PM-
SMCs than in NE-SMCs (Fig.4B). Higher expression of HOXC6, B7, C8, A9 and A10 in PM-SMCs 
versus NE-SMCs was confirmed by qPCR (Fig.4C). In contrast, HOXA1 was expressed at similar 
levels in both cell types, and HOXA2 was down-regulated in PM-SMCs (Supplemental Fig.I). In-
vitro-derived NE-SMCs and PM-SMCs thus recapitulate the differences in HOX expression pattern 
observed in adult AA and TA. 
 
Negative feedback regulation between HOXA9 and NF-κB in smooth muscle cells. 
Atherosclerosis is a chronic inflammatory disease,23 and the transcription factor NF-κB plays an 
important role in the process of vascular inflammation.24 Previous studies demonstrated that NF-κB 
is activated in the endothelium of athero-susceptible regions,25, 26 and is downregulated by HOXA9 
in human endothelial cells.27 Consistent with these findings, our microarray studies show lower 
expression of the NF-κB targets E-selectin, galectin 3 and cxcl5 in the athero-resistant TA. However, 
it remains to be established whether HOXA9 and NF-κB are functionally related in SMCs and 
whether such a relationship contributes to differential expression or activity of these transcription 
factors in the adult vasculature. To tackle this question, we performed electrophoretic mobility shift 
assays (EMSA) on extracts of aortic tissue or primary SMCs. Incubation of mouse aortic extracts 
with a radiolabeled probe containing the consensus DNA-binding site for NF-κB generated a 
retarded band that was efficiently competed out with an excess of unlabeled consensus 
oligonucleotide, but not with an equivalent molar excess of the mutated sequence (Fig.5A, ln.1-3). 
This retarded band was supershifted upon incubation with an antibody against the NF-κB subunit 
p65, but not with an antibody against the unrelated protein CREB II (Fig.5A, ln.4-5). Similarly, 
incubation of rat aortic SMC extracts with the radiolabeled NF-κB consensus binding site generated 
a retarded band that was competed with an excess of unlabeled consensus sequence but not with 
equivalent amount of the mutated sequence (Fig.5A, ln. 6-8). This retarded band was also 
abrogated/supershifted using two anti-p65 antibodies but not with anti-CREB II (Fig.5A, ln.9-11). 
These results demonstrate that murine aorta and aortic SMCs exhibit NF-κB DNA-binding activity. 
Importantly, we found higher NF-κB DNA-binding activity in mouse AA and mouse and rat AA-SMCs 
than in their TA counterparts, although differences did not reach statistical significance for mouse 
AA and TA (Fig.5B, Fig.5C). Accordingly, we observed higher expression of NF-κB targets in 
mouse AA and AA-SMCs than in their TA counterparts, examined by western blot analysis (Fig.5D) 
and flow cytometry (Fig.5E). 
We next investigated whether HOXA9 regulates NF-κB activity in SMCs. For this analysis, 
SMCs were transiently transfected with the 5xNF-κB-luciferase reporter construct, in which 
luciferase expression is driven by a tandem repeat of five NF-κB binding sites. Ectopic expression of 
human HOXA9, but not HOXA2, significantly reduced 5xNF-κB-luciferase activity in rat aortic E19P 
cells and, as expected, overexpression of the NF-κB super-repressor mut IκBα28 reduced 5xNF-κB-
luciferase activity (Fig.6A, top graph). Similar results were obtained in mouse and rat AA-SMCs 
(Fig.6A, middle and bottom graphs, respectively), which have higher NF-κB activity and lower 
Hoxa9 expression than their TA counterparts. Thus, overexpression of HOXA9 significantly inhibits 
NF-κB-dependent transcription in rat aorta E19P cells and AA-SMCs. 
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We also examined whether NF-κB can inhibit transcription driven by the human HOXA9 
promoter. Activity of the HOXA9 promoter-luciferase reporter was inhibited in E19P cells by co-
transfection of NF-κB/p65 or treatment with TNFα (Fig.6B, top graph). The inhibitory effect of TNFα 
was abrogated by co-transfecting mut IκBα, demonstrating the involvement of NF-κB (Fig.6B, top 
graph). Similarly, NF-κB/p65 overexpression significantly inhibited HOXA9 promoter-luciferase 
activity in mouse and rat TA-SMCs (Fig.6B, middle and bottom graphs, respectively), which have 
lower NF-κB activity and higher Hoxa9 expression than their AA counterparts. Moreover, 
transfection with NF-κB/p65 or treatment with TNFα downregulated Hoxa9 mRNA expression in rat 
E19P cells (Fig.6C).  
To further examine the role of Hoxa9 in the regulation of NF-κB activity, we performed loss-of-
function experiments in E19P and TA-SMCs. Cells were transiently transfected with Hoxa9-siRNA or 
control-siRNA and protein expression was analyzed by flow cytometry. Compared with control-
siRNA, Hoxa9-siRNA reduced the levels of endogenous Hoxa9 protein without affecting β-actin 
expression, and this was accompanied by increased expression of the NF-κB targets Stat 5, c-myc 
and E-selectin (Fig.6D). Taken together, these results demonstrate higher NF-κB DNA-binding 
activity in athero-susceptible AA and AA-SMCs than in athero-resistant TA and TA-SMCs, and that 








The main objective of the present study was to identify factors involved in establishing vascular 
heterogeneity that may contribute to atherosclerosis development in adulthood. Our high-throughput 
microarray studies were carried out in young mice fed standard chow, in which atherosclerotic 
lesions were either absent (wild-type) or absent/very incipient (apoE-KO). This allowed us to detect 
genes differentially regulated in athero-prone AA and athero-resistant TA at pre-lesional stages, 
which may therefore be causally related to atherosclerosis development at later phases. Although 
we identified genes that were differentially expressed only in wild-type mice (27 genes) or only in 
apoE-KO mice (127 genes), we focused on the 219 genes that were altered in AA versus TA in both 
wild-type and apoE-KO mice, since these are more likely to be regulated by positional cues 
independently of genotype. Among these genes, Hox cluster genes 6-10 are highly expressed in 
mouse TA compared with AA. We also demonstrate that Hox genes are highly expressed in adult rat 
and swine TA compared with AA. This pattern of Hox-specified positional identity in the adult 
vasculature of mammals is also observed in developmental origin-specific human SMCs derived in 
vitro from embryonic stem cells, and is maintained in mouse and rat primary SMCs isolated from 
adult AA and TA and cultured under static conditions. We have also shown reciprocal negative 
regulation between HOXA9, which is highly expressed in TA, and the pro-inflammatory and pro-
atherogenic transcription factor NF-κB, which is more active in AA. Based on these results in tissue 
and SMCs obtained from wild-type mice and rats, we propose that embryonically-imprinted 
differential Hox expression may contribute to the establishment of distinct regional molecular 
signatures in the adult vasculature that are of likely importance in pathophysiological processes 
(Fig.6E).  
Although our results in aortic tissue and SMC cultures are qualitatively consistent for most of 
the studied Hox genes (higher expression in TA and TA-SMCs versus AA and AA-SMCs), there are 
some dissimilarities in the size of the differences between aortic tissue and SMC cultures; for 
example, Hoxa10 level is ∼10-fold higher in mouse TA versus AA, but ∼80-fold in TA-SMC versus 
AA-SMC (Fig.3A), and the Hoxa9 level is >60-fold higher in rat TA versus AA, but only ∼8-fold 
higher in TA-SMC versus AA-SMC) (Supplemental Fig.I). These differences suggest that 
homeobox gene expression in SMCs might be affected by cues from other neighbouring mural cell 
types, which might also exhibit AA versus TA differences in Hox gene expression. It would be 
therefore interesting to perform in situ hybridization experiments in AA and TA to identify the cell 
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types expressing Hox genes, which might also reveal unknown gradients of Hox gene expression. 
To further explore the relationships between Hox expression and athero-susceptibility in different 
vascular cells, these in situ studies should also include other vessels. For example, it would be of 
interest to examine the athero-prone abdominal aorta, which contains SMCs of somitic-mesoderm 
origin, like the athero-resistant TA, and the athero-prone carotid artery, which contains SMCs from 
neural crest origin, like the athero-susceptible AA.7, 8, 21  
The Hox transcription factors are known to be involved in determining positional identity and 
tissue specialization in the developing embryo in a wide range of evolutionarily distant animal 
species, including Caenorhabditis elegans, Amphioxus, Drosophila, fish, frog, chick, mouse and 
humans.17-20 Comprehensive expression profiling of highly homologous Hox genes in different post-
natal and adult tissues suggests a continuation of embryonic patterning;29-31 however, the functions 
of Hox genes after birth remain largely unexplored and subject to speculation.31 Previous studies 
have implicated a few individual Hox and non-clustered homeobox genes in physiological and 
pathological cardiovascular remodelling (reviewed in32-34). For example, Miano et al.35 observed 
preferential HOXB7 and HOXC9 mRNA expression in fetal compared with adult SMCs and in rat 
pup versus adult SMCs, consistent with the notion that differential HOX expression may contribute 
to establishing phenotypic diversity in VSMCs. Moreover, Chi et al.36 found that human SMCs 
isolated from different adult anatomical sites (bronchus, vein, artery, urinary tract, colon, uterus, 
cervix) can be clustered based solely on their pattern of expression of 63 homeobox genes, and 
suggested that positional information encoded in the pattern of HOX genes may play an important 
role in determining the distinct molecular phenotypes of SMCs from different organs. However, 
these authors did not compare differences in HOX gene expression between vascular SMCs 
obtained from different arteries, such as aorta and the coronary, pulmonary, iliac and umbilical 
arteries. Indeed, information on the expression of Hox genes in different regions of the adult 
vasculature is very scarce, with only a few studies analyzing the expression of a limited number of 
individual family members and their correlation with susceptibility to vascular pathologies.25, 37-40 
Endogenous gene expression studies and reporter gene analysis in transgenic mice revealed Hoxa3 
and Hoxc11 expression in subsets of vascular SMCs and endothelial cells located in distinct regions 
of the adult vasculature that roughly corresponded to the embryonic expression domains of the two 
genes.39 Higher HOXA1 and lower HOXA9 and HOXA10 expression were found in swine 
endothelium from athero-susceptible compared with athero-resistant vessels.25, 37, 40 Moreover, 
HOXA4 expression is lower in the adult baboon abdominal aorta than in the TA and in human 
abdominal aortic aneurysms than in control tissue.38 As a first step toward understanding the 
intrinsic phenotypic differences between arterial segments with distinct susceptibility to 
atherosclerosis, we performed high-throughput transcriptomic analysis of mouse athero-resistant TA 
and atherosclerosis-prone AA. To our knowledge, our unbiased analysis of wild-type and apoE-KO 
mice is the first to identify a spatially coordinated and concerted expression of all members of the 
Hox paralogous groups 6-10 along the mature aorta, with higher expression of Hox6-10 in TA than 
in AA. Importantly, we confirmed these results in TA and AA from adult rats and pigs. These findings 
are in agreement with the well-established notion of spatial colinearity of Hox genes during 
embryonic development, with the most downstream (3´) and upstream (5´) members of each cluster 
being expressed predominantly in anterior and posterior regions, respectively.17-20  
The AA and TA are subject to different fluid mechanical forces generated by distinct blood 
flow patterns, and these forces make a central contribution to determining atherosclerosis 
susceptibility at least in part by establishing specific genetic regulatory programs.4-6 Therefore 
differences in Hox6-10 gene expression along the aorta might be imposed by hemodynamic factors. 
Although we find that the differences between AA and TA observed in vivo persist in primary AA-
SMCs and TA-SMCs cultured under static conditions, we cannot rule out the possibility that blood 
flow-dependent irreversible epigenetic changes imprinted in vivo account for differential Hox6-10 
expression in cultured cells. Likewise, distinct paracrine effects caused by neighboring cells present 
in the vessel wall, including endothelial cells, fibroblasts, and immune cells, might impose 
irreversible epigenetic modifications on SMCs. This is improbable, however, given our studies using 
developmental origin-specific NE-SMCs and PM-SMCs derived from human embryonic stem cells, 
which express markers of differentiated SMCs and recapitulate key phenotypic features of AA-SMCs 
and TA-SMCs, respectively.22 Although these in-vitro-derived cells have never been exposed to fluid 
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mechanical forces and were not co-cultured with other cell types, we found higher HOX6-10 
expression in PM-SMCs than in NE-SMCs. These results support the idea that higher Hox6-10 
expression in TA is caused by hard-wired embryonic programs and not post-natal environmental 
cues.  
Differential Hox6-10 expression between the AA and TA might be a conserved mechanism 
that helps to explain why these vessel segments respond differently to common cardiovascular risk 
factors. However, demonstrating such a cause-and-effect relationship is difficult because of the 
involvement of multiple homeobox genes with a high degree of sequence similarity, particularly 
among paralogous Hox genes. Indeed, analysis of genetically-modified mice with altered Hox 
expression has revealed extensive functional compensation, especially among Hox genes from the 
same paralogous group.17 To begin to address the functional consequences of differential Hox gene 
expression in adult AA and TA, we focused on Hoxa9, which is implicated in endothelial cell 
migration, endothelial differentiation of adult progenitor cells, and post-natal neovascularization.41, 42 
Moreover, endothelium from porcine and human athero-susceptible arteries exhibits comparatively 
low HOXA9 mRNA expression and high NF-κB activity.25, 37, 40 However, we are unaware of any 
earlier functional study of HOXA9 in SMCs, a major component of the arterial wall that plays a key 
role in vascular pathophysiology. Our results demonstrate that Hoxa9 expression is lower in AA-
SMCs and athero-susceptible AA than in TA-SMCs and athero-resistant TA, and this correlates with 
higher NF-κB activity and higher expression of NF-κB targets in AA-SMCs and AA. Moreover, in 
agreement with previous studies in endothelial cells,27 our studies in SMCs show that 
overexpression of human HOXA9 inhibits NF-κB activity, which in turn represses reporter gene 
expression driven by the human HOXA9 promoter and rat Hoxa9 mRNA expression. We have also 
shown that inhibition of Hoxa9 in TA-SMCs downregulates the expression of NF-κB target genes. 
These findings suggest that reciprocal inhibition between HOXA9 and NF-κB in endothelial cells and 
SMCs contributes to differences in athero-suceptibility between AA and TA (Fig.6E). Since our 
functional studies were carried out with SMCs obtained from wild-type rodents, future studies will be 
needed to ascertain whether this model can be applied in the setting of the chronic inflammatory 
stress that characterizes atherosclerosis progression. Further high-throughput studies are also 
warranted to identify the repertoire of genes differentially regulated in AA versus TA as a result of 
differential Hox6-10 expression, which may shed light on the molecular mechanisms underlying the 
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Different blood vessels and distinct segments within a given artery are heterogeneous in 
their susceptibility to developing vascular pathologies in response to common risk factors, 
but the molecular mechanisms underlying these differences are incompletely understood. 
Here, we show that homeobox cluster genes 6-10 are highly expressed in mouse athero-
resistant thoracic aorta (TA) compared with athero-pone aortic arch (AA). This pattern of 
Hox-specified positional identity is maintained in adult rat and swine TA compared with AA, 
in mouse and rat primary smooth muscle cells (SMCs) isolated from adult AA and TA, and in 
developmental origin-specific human SMCs derived in vitro from embryonic stem cells and 
cultured under static conditions. We also show that differential Hox expression contributes to 
maintaining phenotypic differences between SMCs from athero-resistant and athero-
susceptible regions, at least in part through feedback regulatory mechanisms involving 






Figure 1. Rationale and design of high-throughput analysis of atherosclerosis-related gene 
expression in mouse aorta. Three-month-old wild-type and apoE-KO mice were fed low-fat 
standard chow. (A) Total plasma cholesterol (n=6 mice per genotype). (B) Representative images of 
macrophage-specific anti-Mac3 immunostaining showing incipient atherosclerotic lesions in aortic 
sinus of apoE-KO mice (brown staining). (C) AA and TA were extracted from 12 mice of each 
genotype, and tissue was pooled to isolate total RNA for microarray studies. Using the criteria 
described in Material and Methods, 122 transcripts exhibited differential regulation between TA and 
AA only in apoE-KO mice (Supplemental Table II), 27 only in wild-type mice (Supplemental Table 
III), and 219 in mice of both genotypes (Supplemental Table IV).  
 
Figure 2. Homeobox gene expression in mouse aorta. (A) Microarray studies revealed higher 
level of expression of thirteen homeobox genes in TA versus AA (11 in both genotypes, and Hoxc8 
and Hoxb8 only in apoE-KO mice). (B) Representation of the four homeobox clusters (a-d) and 
individual Hox genes (1-13), showing members that are expressed at similar levels in AA and TA 
(white boxes) or upregulated (grey boxes) in TA versus AA.  
 
Figure 3. Homeobox expression in mouse aortic tissue and primary SMCs. Three-month-old 
wild-type mice fed standard chow were sacrificed, and total RNA or protein was isolated from aortic 
tissue (pools of 3 AAs or TAs) or primary SMCs (established in culture from pools of 5 AAs or TAs). 
(A) Hox gene expression quantified by qPCR using 18S as an internal control. Results are 
presented in arbitrary units normalized to expression in AA (=1). Data are means±SEM of 4 
independent extractions for mouse aortic tissue and 5 independent extractions for mouse SMCs, 
measured in triplicate. *: p<0.05; **: p< 0.01; ***: p<0.001. (B) Hoxa9 and Hoxc8 protein expression 
in lysates from 3 independent pools analyzed by Western blot. GAPDH was used as loading control. 
  
Figure 4. Homeobox gene expression in in-vitro-derived human neuroectoderm- and paraxial-
mesoderm-derived SMCs. (A) Scheme of in vitro derivation of NE-SMCs and PM-SMCs from 
human embryonic stem cells (hEPSCs). (B) HOX genes upregulated in PM-SMCs versus NE-SMCs, 
as revealed by microarray analysis. (C) qPCR analysis of HOX gene expression. Results are 
presented in arbitrary units normalized to NE-SMCs (mean±SEM, n=3). *: p<0.05; **: p< 0.01; ***: 
p<0.001.  
 
Figure 5. NF-κB DNA-binding activity and target gene expression are higher in aortic arch 
and AA-SMCs compared with thoracic aorta and TA-SMCs. (A-C) EMSA using cell lysates and a 
radiolabeled oligonucleotide containing the NF-κB consensus DNA-binding site. Representative 
autoradiographs are shown and quantitative data in B and C are means±SEM of the indicated 
number of independent experiments. In the EMSA of each panel all binding reactions were run in 
the same gel and exposed to the same X Ray film.  Cell lysates in A were prepared from mouse TA 
(left) and TNFα-treated rat primary TA-SMCs (right). For competition assays, binding reactions 
included a 100-fold excess of unlabeled NF-κB consensus oligonucleotide or a mutant sequence 
that disrupts NF-κB binding. For supershift experiments, antibodies against p65 (1: sc-372; 2: sc-
109) or CREBII (negative control) were added to binding reactions. Cell lysates in B and C were 
prepared from AA and TA, or from AA-SMCs and TA-SMCs isolated from wild-type mice or rat, as 
indicated. The autoradiographs only show the retarded nucleo-protein complexes. *: p<0.05; **: p< 
0.01. (D) Western blot analysis of mouse AA and TA. (E) Protein expression in AA-SMCs and TA-
SMCs analyzed by flow cytometry. 
  
Figure 6. HOXA9 and NF-κB inhibit each other in SMCs. Experiments were performed with rat 
embryonic aortic E19P cells, and primary mouse or rat AA- or TA-SMCs, as indicated. (A) Cells 
were transfected with a luciferase reporter gene containing a tandem repeat of five NF-κB binding 
sites (5xNF-κB-luciferase) plus pRL-TK renilla as a control for transfection efficiency. When 
indicated, cells were co-transfected with HOXA9 (pcDNA3.1+-HOXA9), HOXA2 (pcDNA3.1+-
14 
 
HOXA2) or mut IκBα (IκBα S32/36A, NF-κB super-repressor). One day after transfection, cells were 
lysed and luciferase activity measured. Data are means±SEM of 4 to 7 independent experiments. 
(B) Cells were transfected with pGL3 basic-HOXA9 promoter-luciferase reporter plasmid plus pRL-
TK renilla. When indicated, cells were co-transfected with mut IκBα or p65-GFP (subunit of NF-κB 
complex), and/or treated with TNFα (10 ng/ml during the last 4 hrs). Luciferase activity was 
measured after 24h. Data are means±SEM of 3 to 6 independent experiments. (C) E19P cells were 
untreated, exposed to TNFα (10 ng/ml, 4 hrs), or transiently transfected with p65-GFP, and total 
RNA was isolated for qPCR to quantify Hoxa9 expression using 18S as an endogenous control. 
Results are means±SEM of 4 independent experiments measured in triplicate (arbitrary units 
normalized to control cells). (D) Cells were transiently transfected with Hoxa9-siRNA or control-
siRNA. Transfected cells were detached and levels of the indicated proteins were measured by flow 
cytometry. (E) Proposed model for the reciprocal modulation of NF-κB and HOXA9 in the adult 
aorta. *: p<0.05; **: p< 0.01; ***: p<0.001. 
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MATERIALS AND METHODS 
 
Animals. Male apolipoprotein E-null mice (apoE-KO) and wild-type mice (both C57BL/6J 
genetic background, Charles River Laboratories, Wilmington, Massachusetts, USA) were 
maintained on a low-fat standard diet (2.8% fat, Panlab, Barcelona, Spain) and were 
sacrificed at 3 months of age. Male Wistar rats (200-400 g, Charles River Laboratories) 
were sacrificed at 3 to 5 months of age. Castrated male Large-White pigs (bred on the 
CNIC’s farm) were sacrificed at 3 to 4.5 months of age. All animal procedures conformed to 
Directive 2010/63EU and Recommendation 2007/526/EC regarding the protection of 
animals used for experimental and other scientific purposes, enforced in Spanish law under 
Real Decreto 1201/2005.  
 
Microarray studies. Twelve mice of each genotype were sacrificed to isolate the AA and 
the TA. The aorta was removed, placed on a Petri dish containing ice-cold PBS and 
cleaned of surrounding fat and non-vascular tissue under a stereo microscope (Olympus 
SZX10, Olympus Iberia, Barcelona, Spain). Further dissection yielded the AA (from 3 mm 
above the aortic root to 2 mm past the left subclavian artery) and TA (from 2 mm past the 
left subclavian artery to the diaphragm insertion) (Fig.1C). Four pools each containing 3 
AAs or 3 TAs were processed for total RNA isolation using Qiazol and the miRNeasy Mini 
kit (Fig.1C). RNA concentration and purity were assessed from the A260nm/A280nm ratio, 
and integrity was verified by separation on ethidium bromide-stained 1% agarose gels. RNA 
was amplified and labeled using the One-Color Microarray-Based Gene Expression 
Analysis Protocol (Agilent Technologies, Palo Alto, CA, USA). Samples were hybridized to 
a Mouse Whole Genome Oligo Microarray (4x44K; G4122F, Agilent Technologies). 
Cyanine-3-labeled aRNAs (1.65 µg) were hybridized for 17 h in a final concentration of 1x 
GEx Hybridization Buffer HI-RPM (Agilent Technologies) at 65ºC in an Agilent hybridization 
oven (G2545A, Agilent Technologies) set to 10 rpm. Arrays were washed and dried 
according to the manufacturer's instructions (One-Color Microarray-Based Gene 
Expression Analysis, Agilent Technologies), and were scanned at 5mm resolution on an 
Agilent DNA Microarray Scanner (G2565BA, Agilent Technologies) using the default 
settings for 4x44k format one-color arrays. Images generated by the scanner were 
analyzed using Feature Extraction software v10.1.1.1 (Agilent Technologies). Data were 
normalized using the quantiles method. Two arrays that were identified as statistical outliers 
by the array QualityMetrics Bioconductor package were excluded from further analysis. 
From the original set of probes only those with a good flag and with a signal above the 20% 
overall array signal in at least three samples were subjected to statistical analysis. Probes 
showing no change (cv<25%) across all samples were also excluded from the analysis 
(13597 probes remaining). To detect genes differentially expressed between different 
conditions, we used a mixed effects model as implemented in the Limma Bioconductor 
package. The fixed effects were the genotype (apoE-KO/wild-type) and the region of the 
aorta (AA versus TA), and the mouse pool was considered a random effect. Changes were 
considered significant at an adjusted Benjamini-Hochberg p-value ≤ 0.05. 
The Illumina HumanHT-12 v4 BeadArray was used to acquire genome-wide 
expression data from neuroectoderm-derived and paraxial mesoderm-derived smooth 
muscle cells (NE-SMCs and PM-SMCs, respectively). Data were processed as previously 
described.1 Data are available from the ArrayExpress microarray data repository under the 
accession number E-MTAB-781.  
 
Plasma cholesterol. Mice were fasted overnight and blood was withdrawn from the cheek. 
Plasma cholesterol levels were measured using an enzymatic procedure (WAKO, St. Louis, 
Missouri, USA). 
 
Cell culture. Cells were maintained at 37ºC and 5% CO2 in Dulbecco's Modified Minimal 
Essential Medium (DMEM) (Sigma, St. Louis, Missouri, USA) supplemented with 10% heat-
inactivated fetal bovine serum (FBS, Sigma), 1% glutamine and 1% penicillin/streptomycin. 
When indicated, cells were treated for 4 h with recombinant murine tumor necrosis factor α 
(TNF-α, 10 ng/ml, ref. 315-01A, Peprotech EC Ltd, London, UK). 
The rat embryonic aorta cell line E19P was kindly provided by C. Shanahan (King’s 
College London, UK). Mouse primary SMCs were isolated from a pool of 5 TAs or 5 AAs 
harvested from 3-month-old wild-type mice after 2 digestions in HBSS/fungizone medium. 
Briefly, the mouse aorta was first digested with type II collagenase (175 U/ml) (ref. 4176, 
Worthington Biochemical Corp., Lakewood, New Jersey, USA) to remove the adventitia and 
SMC suspensions were obtained after a second digestion with type II collagenase (175 
U/ml) and type I elastase (4.7 U/ml) (ref. 45124, Sigma). For the preparation of primary rat 
SMCs, rat aortas were harvested and first digested with type II collagenase (590 U/ml) (ref. 
4176, Worthington) in DMEM for 20 minutes at 37ºC and the adventitia was completely 
removed. Tissue was then cut in rings, maintained with agitation for 2h at 37ºC, and cells 
were plated in 6-well dishes. Mouse and rat SMCs were initially cultured in DMEM with 20% 
FBS and 1% fungizone/penicillin/streptomycin/glutamine, and afterwards as described 
above. Mouse and rat primary cells from passages 4 to 10 were used for experiments. The 
identity of AA and TA SMCs was confirmed by immunocytochemistry with a cyanine-3-
conjugated anti-smooth-muscle-α-actin antibody (1/200 dilution) (clone 1A4, c-6198, 
Sigma).2 
Human embryonic stem cells (line H9, WiCell, Madison, WI, USA, passages 65-85) 
were cultured and differentiated into neuroectoderm-derived SMCs (NE-SMC) and paraxial 
mesoderm-derived SMCs (PM-SMC) under chemically-defined conditions as previously 
described.1  
 
Mac-3 immunostaining. Mice were sacrificed and their heart and aorta were removed after 
in situ perfusion with PBS. For Mac-3 immunostaining, the protion of the heart containing 
the aortic sinus was fixed with freshly prepared 4% paraformaldehyde/PBS overnight at 
4°C. After fixation, the tissue was paraffin-embedded and 3-µm cross-sections were 
prepared for immunostaining with rat monoclonal anti-Mac3 antibody (1/200 dilution, clone 
M3/84, sc-19991, Santa Cruz Biotechnology, Santa Cruz, California, USA), followed by 
incubation with biotin-conjugated goat anti-rat secondary antibody (1/300 dilution, sc-2041, 
Santa Cruz Biotechnology), and streptavidin-HRP (TS-060-HR, Lab Vision Corporation, 
Fremont, California, USA). Immunocomplexes were detected with DAB substrate 
(BUF021A, AbD Serotec, Kidlington, UK) and specimens were counterstained with 
hematoxylin. 
 
Quantitative real-time polymerase chain reaction (qPCR). Animals were sacrificed to 
isolate total RNA from aortic tissue (for mice, 4 pools of 3 AAs or TAs different from those 
used for microarray studies) or primary SMCs (for mice, pools were prepared from 5 AA or 
TA). Tissue disruption was performed in Qiazol Lysis Reagent using 5mm-diameter 
stainless steel beads and a Tissue-Lyser LT (all from Qiagen, Valencia, California, USA). 
The Tissue-Lyser LT adapter was precooled and used with 10 cycles of 3 minutes at 50 Hz. 
Total RNA was recovered from the aqueous phase and final isolation of RNA was perfomed 
using the miRNeasy Mini kit according to the manufacturer’s instructions (Qiagen). RNA 
concentration and purity were assessed from the A260nm/A280nm ratio. cDNA was 
generated from RNA (0.5-1 g) using random hexamers, RNase Inhibitor and the High 
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, California, 
USA). qPCR was performed with the ABI PRISM 7900HT Sequence Detection System 
using PCR Power SYBR Green PCR Master Mix (both from Applied Biosystems). Total 
RNA from human NE-SMCs and PM-SMCs was extracted with RNeasy Mini Kit (Qiagen) 
and cDNA was prepared with the Maxima First Strand cDNA Synthesis Kit (Fermentas, St. 
Leon-Rot, Germany). qPCR was performed with the 7500 Fast Real-time PCR System 
using SYBR Green PCR Master Mix (Applied Biosystems). Reactions were performed in 
technical duplicates or triplicates using the specific primers shown in Supplemental Table I. 
Relative quantification of gene expression was performed with the internal control 
housekeeping genes ribosomal 18S (for mouse and rat), glyceraldehyde-3-phosphate 
dehydrogenase (for pig), or porphobilinogen deaminase (for human cells). qPCR results 
were analyzed by the comparative Ct method.  
 
Antibodies. Anti-Stat 5 (sc-835), anti-Akt1/2 (sc-1619), anti-PDGF-B (sc-74494), anti- -
Actin (sc-130657), anti NF B p65 (sc-109) and anti-HoxA9 (sc-17155) were from Santa 
Cruz Biotech.; anti-Myc (06-340) was from Upstate; anti-HOXC8 (ab86236) was from 
Abcam and PE conjugated anti-E-selectin (553751) was from BD bioscience. 
 
Immunoblotting. Whole lysates from aorta segments or vascular SMC were subjected to 
SDS-PAGE, and proteins were transferred to PVDF membranes and probed with the 
indicated antibodies in Tris-buffered saline–Tween 20. Bound antibodies were incubated 
with horseradish peroxidase secondary antibodies and membranes were developed by 
enhanced chemiluminescence with Super-Signal West Pico or Femto chemiluminescent 
substrate (Pierce Chemical). 
 
 
Electrophoretic mobility shift assay (EMSA). Double-stranded oligonucleotides 
containing the consensus DNA-binding site for nuclear factor-κB (NF-κB) (5’-
AGTTGAGGGGACTTTCCCAGG-3’, NF-κB binding site underlined) were labeled with 
[32P]dATP (Perkin Elmer, Waltham, Massachusetts, USA) using polynucleotide kinase (New 
England Biolabs, Ipswich, Massachusetts, USA) and purified on a Sephadex G-50 column. 
Total protein extracts (aortic tissue: 15 µg; SMCs: 2 µg) were pre-incubated with 20 mM 
HEPES (N-2-hydroyethylpiperazine-N9-2ethanesulfonic acid) [pH 7.9], 60 mM NaCl, 5 mM 
MgCl2, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 4% glycerol, and 50 µg/ml 
poly[d(I-C)], before the addition of the radiolabeled probe. For competition assays, binding 
reactions included a 100-fold excess of unlabeled oligonucleotide containing the NF- B 
consensus binding site or a mutated sequence that disrupts binding of NF-κB (5’-
AGTTGAGGcGACTTTCCCAGGC-3’, NF- B site underlined and mutated nucleotide in 
lower case). For supershift experiments, lysates were pre-incubated for 25 minutes with 1 
µg of anti-p65 (sc-372 or sc-109) or anti-CREBII (sc-22800X) (all from Santa Cruz 
Biotechnology) before adding radiolabeled probe. Binding reactions were resolved by 
electrophoresis at 4ºC on 5% polyacrylamide gels run in 0.25X TBE buffer under non-
denaturing conditions. Gels were dried and autoradiographied, and the intensity of the 
retarded bands was quantified with Metamorph (Molecular Devices, Sunnyvale, California, 
USA). 
 
Plasmids, siRNAs, transient transfection and dual luciferase activity assay. The 
vectors pcDNA3.1+-HOXA9 (human), pcDNA3.1+-HOXA2 (human), p65-GFP, 5xNF- B-
luciferase (a luciferase reporter gene containing a tandem arrangement of five NF- B 
binding sites) and pGL3-basic human HOXA9 promoter-luciferase were kindly provided by 
Dr. C. Patel.3, 4 The plasmid mut I Bα S32/36A vector (a gift from Dr. P. Muñoz-Canoves) 
encodes an undegradable form of NF- B inhibitor alpha (I Bα) and thus functions as a 
super-repressor of NF B activity. Small interfering RNA against hoxa9 (Hoxa9-siRNA, 
Inventoried Cat. # 4392420; Id. s6774) and control-siRNA (Silencer Select Negative Control 
No. 1 siRNA; Cat. # 4390843) were purchased from Life Technologies (Carlsbad, 
California, USA). One day after seeding in 24-well plates, cells were transiently transfected 
with 0.25, 0.5 or 1.75 µg of total DNA for E19P, mouse SMCs or rat SMCs, respectively, 
using 1, 4 or 8 µl  of  Lipofectamine 2000 (Life Technologies) for E19P, mouse SMCs and 
rat SMCs, respectively. In brief, cells were co-transfected with 0.1, 0.2 or 0.8 µg NF-kB-
luciferase or HOXA9 promoter luciferase vectors and 0.02, 0.04 or 0.15 µg pRL-TK Renilla 
(control for transfection efficiency; Promega, Madison, Wisconsin, USA) for E19P, mouse 
SMCs or rat SMCs, respectively. When indicated, cells were co-transfected with 
pcDNA3.1+-HOXA9, pcDNA3.1+-HOXA2, mut I Bα S32/36A or p65-GFP, with the same 
amount of plasmid than the one used for the corresponding luciferase vectors. When 
indicated, cells were also treated with TNFα (10 ng/ml) during the last 4 hours. One day 
after transfection, cell lysates were prepared and firefly and renilla luciferase activities were 
measured with the Dual Luciferase Reporter Assay kit (Promega) and a Sirius Single Tube 
Luminometer (Berthold Detection Systems, Pforzheim, Germany).  
For the siRNA studies, E19P cells or mouse TA-SMCs were seeded for 1 day in 60 
mm plates and they were transiently transfected with 50 nM siRNA and 5 µl of 
Lipofectamine 2000. 
 
Flow Cytometry. Cells were detached from the plate 1 day after transfection, with the 
exception of the cells used to identify STAT5 that were analysed 2 days after transfection. 
All procedures were performed at room temperature. Cells were fixed with 2% PFA/1% 
sucrose for 30 minutes and permeabilized with 0,5% triton-X100 for 15 minutes before 
staining with the specific primary antibodies (1:200 in PBS) for 1 hour. After several 
washes, cells were incubated with fluorescent secondary antibodies (1:500 in PBS) for 45 
minutes. For PE-E-selectin fluorescent labelling, cells were fixed for 30 minutes with 2% 
PFA/1% sucrose without permeabilization and stained for 30 minutes with PE-E-selectin 
(1:100 in PBS; BD bioscience). Cells were examined on a LSR Fortessa flow cytometer 
(BD Biosciences) and data were analyzed with BD FACSDIVA (BD Biosciences) or FlowJo 
(Inc).  
 
Statistical analysis. Statistical analysis of microarray data is described above. For other 
experiments, results are expressed as means±SEM, and statistical significance was 
evaluated by 2-tailed, unpaired Student’s t test (GraphPad-Prism, GraphPad Software, 
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